share_log

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K：諾和諾德-股票回購計劃
美股SEC公告 ·  09/09 11:10

Moomoo AI 已提取核心訊息

Novo Nordisk A/S, a leading global healthcare company, has reported progress on its share repurchase program. The company, headquartered in Denmark, initiated this program on August 7, 2024, as part of a larger DKK 20 billion buyback plan set to occur over a 12-month period starting February 6, 2024. From August 26 to August 30, 2024, Novo Nordisk repurchased a total of 204,000 B shares at an average price of DKK 910.88, amounting to a transaction value of DKK 185,845,531. This brings the accumulated repurchases under the program to 744,187 B shares for a total cost of DKK 671,844,599. As of August 30, the company owns 13,139,944 B shares as treasury shares, which is 0.3% of the share capital. The total number of A and B shares, including treasury shares, is 4,465,000,000. Since the beginning of the repurchase plan on February 6, 2024, Novo Nordisk has bought back 11,811,313 B shares at an average price of DKK 880.47 per share, totaling DKK 10,399,550,649. Novo Nordisk's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
Novo Nordisk A/S, a leading global healthcare company, has reported progress on its share repurchase program. The company, headquartered in Denmark, initiated this program on August 7, 2024, as part of a larger DKK 20 billion buyback plan set to occur over a 12-month period starting February 6, 2024. From August 26 to August 30, 2024, Novo Nordisk repurchased a total of 204,000 B shares at an average price of DKK 910.88, amounting to a transaction value of DKK 185,845,531. This brings the accumulated repurchases under the program to 744,187 B shares for a total cost of DKK 671,844,599. As of August 30, the company owns 13,139,944 B shares as treasury shares, which is 0.3% of the share capital. The total number of A and B shares, including treasury shares, is 4,465,000,000. Since the beginning of the repurchase plan on February 6, 2024, Novo Nordisk has bought back 11,811,313 B shares at an average price of DKK 880.47 per share, totaling DKK 10,399,550,649. Novo Nordisk's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
全球領先的醫療保健公司諾和諾德已經就其股票回購計劃取得了進展。這家總部位於丹麥的公司自2024年8月7日啓動了該計劃，作爲一項從2024年2月6日開始的爲期12個月的DKk 200億回購計劃的一部分。從2024年8月26日至2024年8月30日，諾和諾德以平均價格DKk 910.88回購了2040000億股，交易價值爲DKk 185,845,531。這使得該計劃下累計回購的股份達到7441870億股，總成本爲DKk 671,844,599。截至2024年8月30日，該公司持有131399440億股作爲財庫股份，佔股本的0.3%。包括財庫股份在內的A股和B股總數爲4,465,000,000。自2024年2月6日開始回購計劃以來，諾和諾德以每股DKk 880.47的平均價格回購了118113130億股，總計DKk 10,399,550,649。諾和諾德的股票在納斯達克哥本哈根交易所上交易，並在紐約證券交易所上交易其ADR股。
全球領先的醫療保健公司諾和諾德已經就其股票回購計劃取得了進展。這家總部位於丹麥的公司自2024年8月7日啓動了該計劃，作爲一項從2024年2月6日開始的爲期12個月的DKk 200億回購計劃的一部分。從2024年8月26日至2024年8月30日，諾和諾德以平均價格DKk 910.88回購了2040000億股，交易價值爲DKk 185,845,531。這使得該計劃下累計回購的股份達到7441870億股，總成本爲DKk 671,844,599。截至2024年8月30日，該公司持有131399440億股作爲財庫股份，佔股本的0.3%。包括財庫股份在內的A股和B股總數爲4,465,000,000。自2024年2月6日開始回購計劃以來，諾和諾德以每股DKk 880.47的平均價格回購了118113130億股，總計DKk 10,399,550,649。諾和諾德的股票在納斯達克哥本哈根交易所上交易，並在紐約證券交易所上交易其ADR股。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間